Lee Kalowski, Chief Financial Officer at Tokai Pharmaceuticals Inc (TKAI), sold 4,668 shares at $13.13 ($61K) on 2015-09-08, disclosed to the SEC on 2015-09-08.
Scheduled sale ($61k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| QTTB | SELL | 2025-12-04 | $31K | — | Filing → |
| QTTB | SELL | 2025-08-28 | $8K | — | Filing → |
| BCYC | SELL | 2023-04-05 | $8K | — | Filing → |